Abbott Laboratories (ABT) News

Abbott Laboratories (ABT)

Today's Latest Price: $104.22 USD

0.78 (-0.74%)

Updated Oct 30 1:11pm

Add ABT to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

Filter ABT News Items

ABT News Results

Event/Time Symbol Company News Detail Start End Change POWR Rating
Loading, please wait...

Latest ABT News From Around the Web

Below are the latest news stories about Abbott Laboratories that investors may wish to consider to help them evaluate ABT as an investment opportunity.

Electrophysiology Devices Market 2020-2027 Study And Future Prospects Including Key Players Abbott Laboratories, Bio sense Webster, BIOTRONIK SE & Co. KG, Etc.

The latest updated report on the Global Electrophysiology Devices Market added by Reports and Data presents a comprehensive analysis of the industry size, revenue forecast, regional spectrum of the business vertical, and further elaborates on the major hurdles, challenges, and

OpenPR | October 2, 2020

Beating COVID-19 With The Pacer BioThreat Strategy ETF (Podcast Transcript)

Editors' Note: This is the transcript of the podcast we posted last week. Please note that due to time and audio constraints, transcription may not be perfect. We encourage you to listen to the podcast, embedded below, if you need any clarification. We hope you enjoy. Sign up for Let's...

Let's Talk ETFs on Seeking Alpha | September 30, 2020

Emergency Medical Supplies Market Is Booming Worldwide | Bayer Corporation, the 3M Company, Abbott Laboratories

Emergency Medical Supplies Market - Industry Dynamics, Market Size, Opportunity And Forecast To 2026, Covid 19 Outbreak Impact research report added by Report Ocean, is an in-depth analysis of market characteristics, size and growth, segmentation, regional and country breakdowns, competitive

OpenPR | September 30, 2020

Abbott exec: Why better COVID-19 tests may help the U.S. get back to normal

As the executive running the virus surveillance program at Abbott Laboratories, one of the nation’s largest diagnostics companies, John Hackett is one busy man.

MarketWatch | September 30, 2020

Dividend Aristocrats In The Defensive Sectors

This article provides an update to the article I wrote in March: Since my March article, several changes have been made to the Dividend Aristocrats, and the stock market has mostly recovered from the crash in late February and early March. There are now 65 Dividend Aristocrats and, given growing...

FerdiS on Seeking Alpha | September 29, 2020

Canada agrees to buy almost 8M rapid COVID-19 tests from Abbott

The Canadian government inks an agreement with Abbott ([[ABT]] +0.8%) to purchase 7.9M COVID-19 rapid point-of-care tests, branded as ID NOW, that can generate results from a nasal swab in as little as 13 minutes. The deal is an advance purchase agreement since Health Canada has yet to approve it...

Seeking Alpha | September 29, 2020

Transplant Diagnostics Market With Current Trends Analysis 2020: Omixon Ltd., CareDx, Affymetrix, Inc, Abbott Laboratories, Inc, Thermo Fisher Scientific, Inc

The Business Research Company offers " Transplant Diagnostics Global Market Report 2020-30: Covid 19 Growth And Change" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective

OpenPR | September 29, 2020

Stress Management Market (Impact of Covid-19) With Top Players like Abbott Laboratories, Eli Lilly and Co., GlaxoSmithKline PLC, Lupin Ltd., Johnson & Johnson Services Inc., Merck & Co. Inc., Pfizer Inc., Fitbit, Azumio, H. Lundbeck A/S

An off-the-shelf report on Stress Management Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such as

OpenPR | September 29, 2020

Feds announce plan to buy 7.9 million rapid COVID tests

Public Services and Procurement Minister Anita Anand today announced today a plan to buy roughly 7.9 million rapid point-of-care COVID-19 tests from U.S.-based Abbott Laboratories.

CBC News | September 29, 2020

Abbott next-gen continuous glucose monitor CE Mark'd

Abbott (ABT) announces CE Mark certification of its FreeStyle Libre 3 system that features a small thin wearable glucose sensor (about the size to two stacked pennies) that can be worn up to 14 days.Shares up 1% premarket on light volume....

Seeking Alpha | September 28, 2020

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.554 seconds.